Company / Profit Margin
NOVAVAX INC Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
39.2%
FY2025
5-year range
-152.1% / 39.2%
FY2021-FY2025
Trend
+242.6%
vs FY2024
Sector context
#11 of 145
Health Care
What the data says
Profit Margin changed +243% YoY in FY2025, a notable deviation from the 9-year average annual change of +8%.
Based on SEC 10-K filings.
39.2% in FY2025 with a 5-year CAGR of +127.1%. Top quartile in the Health Care sector.
Improved from -55.4% to 39.2% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +127.1pp
- 5-Year Change
- +127.1pp
- 10-Year Change
- -
Sector benchmark
Top 8% in Health CareTop 8% of 145This company 39.2% Sector average -792.7%
▼
+104.9% above sector average
Key checks
Key Insights
- NOVAVAX INC's profit margin has grown for 4 consecutive years.
- In FY2025, profit margin increased 242.6% year-over-year.
- Currently 831.9pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 39.2% | +242.6% |
| FY2024 | -27.5% | +50.4% |
| FY2023 | -55.4% | +37.0% |
| FY2022 | -87.9% | +42.2% |
| FY2021 | -152.1% | -73.0% |
| FY2020 | -87.9% | +85.1% |
| FY2019 | -589.5% | +67.7% |
| FY2018 | -1823.5% | -321.2% |
| FY2017 | -432.9% | -60.0% |
| FY2016 | -270.5% | -8.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026